Lifestyle factors (obesity, physical inactivity, and stress) seem to be the main drivers of the current diabetes epidemic. With aggressive prevention of obesity in all age groups, type 2 diabetes is potentially preventable. Several clinical trials have shown that weight loss is associated with delayed or decreased onset of diabetes in high-risk adults. Progression to diabetes from pre-diabetic states can be reduced by 50% over 3 to 4 years through modest weight loss (7% of body weight) using diet and regular physical activity. [ ] In addition, several pharmacological agents, including metformin, alpha-glucosidase inhibitors, orlistat, glucagon-like peptide 1 (GLP-1) receptor agonists, and thiazolidinediones, have been shown to reduce progression from pre-diabetes to diabetes. Lifestyle change and/or metformin are preferred for most patients. More aggressive multi-agent pharmacological approaches remain controversial. Screening for pre-diabetes and cardiovascular risk reduction appropriate to the needs of the individual are also very important.
Although the risk of macrovascular complications can be reduced by over 50% using effective multifactorial interventions, a US national survey found more than half of outpatients over age 50 years with diabetes and hypertension did not receive an antiplatelet agent, statin therapy, or ACE inhibitor/angiotensin-II receptor antagonist.
Other preventative measures include:
Annual influenza immunisations
Vaccination against pneumococcal disease
Hepatitis B vaccination for unvaccinated diabetic adults aged 19 to 59 years; considered for unvaccinated diabetic adults aged 60 years and older
Regular dental care
Tailored diabetes education.
Use of this content is subject to our disclaimer